Login / Signup

Multicenter expanded access program for access to investigational products for amyotrophic lateral sclerosis.

Dylan V NeelClara Baselga-GarrigaMolly BensonMackenzie KeeganMarianne ChaseDerek D'AgostinoKristin DrakeJennifer Linn HagarMeredith Gibbons HasenoehrlJennifer Kulesa-KelleyAlex LeiteSilpa MohapatraSusanna Marie PortaroLindsay M PothierJesse RosenthalAlexander V ShermanHong YuAlexandra McCaffreyDoreen HoSarah LuppinoRichard Stanley BedlackDaragh HeitzmanSenda Ajroud-DrissJonathan KatzKevin FeliceCharles WhitakerShafeeq LadhaGustavo AlamedaEduardo LocatelliIrfan A QureshiMichael T HotchkinMichael R HaydenMerit E CudkowiczSuma BabuJames D BerrySabrina Paganoni
Published in: Muscle & nerve (2024)
Multicenter EAPs conducted in parallel to randomized clinical trials for ALS can successfully enroll participants who do not qualify for clinical trials.
Keyphrases
  • amyotrophic lateral sclerosis
  • clinical trial
  • double blind
  • phase ii
  • cross sectional
  • quality improvement
  • randomized controlled trial
  • open label
  • placebo controlled
  • phase iii